Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Successful Peripheral Blood Stem Cell (PBSC) Mobilisation with G-CSF in Patients with Chronic Myeloid Leukaemia Achieving Complete Cytogenetic Remission with Imatinib.

A.M. Carella, MD, Maria T. Corsetti, MD, Carlo Bodenizza, MD, Francesco Iuliano, MD, Giulia Pucci, MD, Pasquale Jacopino, MD, Bruno Martino, MD, Maura Brugiatelli, MD, Felicetto Ferrara, MD

Blood (2004) 104 (11): 4652.

https://doi.org/10.1182/blood.V104.11.4652.4652

Published: 2004

Journal Articles

Imatinib Achieves High Rates of Complete Citogenetic Remission (CCR) in CML Patients Relapsed after Autografting anf IFN-α Therapy.

Maria T. Corsetti, MD, Germana Beltrami, MD, A.M. Carella, MD

Blood (2004) 104 (11): 4656.

https://doi.org/10.1182/blood.V104.11.4656.4656

Published: 2004

Journal Articles

Reduced Intensity Conditioning Regimen for Allografting Following Cytoreductive Autografting in Metastatic Breast Cancer.

A.M. Carella, MD, Germana Beltrami, MD, Maria T. Corsetti, MD, Potito Scalzulli, MD, Michele Carella, MD, Roberta Gonella, MD, Alberto Ballestreo, MD, Franco Patrone, MD

Blood (2004) 104 (11): 5129.

https://doi.org/10.1182/blood.V104.11.5129.5129

Published: 2004

Journal Articles

Reduced Intensity Conditioning Regimen for Allografting Following Autografting Is Feasible and Has a Strong Anti Multiple Myeloma Activity.

A.M. Carella, MD, Germana Beltrami, MD, Maria T. Corsetti, MD, Potito Scalzulli, MD, Nicola Cascavilla, MD, Michele Carella, MD, Sandro Nati, MD, Mario M. Greco, MD, Pellegrino Musto, MD

Blood (2004) 104 (11): 5130.

https://doi.org/10.1182/blood.V104.11.5130.5130

Published: 2004

Journal Articles

Long-Term Follow-Up of CML Patients Treated with Autografting Followed by IFN-A and Imatinib for Relapsed Patients.

A.M. Carella, MD, Maria T. Corsetti, MD, Germana Beltrami, MD, Carlo Bodenizza, MD, Marina Cavaliere, MD

Blood (2004) 104 (11): 5217.

https://doi.org/10.1182/blood.V104.11.5217.5217

Published: 2004

Journal Articles

Reduced Intensity Conditioning Regimen for Allografting Following Cytoreductive Autografting in Relapsed/Resistant Hodgkin’s Lymphoma.

Michele Carella, MD, Germana Beltrami, MD, Maria T. Corsetti, MD, Mario M. Greco, MD, Potito Scalzulli, MD, Nicola Cascavilla, MD, Pellegrino Musto, MD, Antonio La Sala, MD, Matteo Dell’Olio, MD, A.M. Carella, MD

Blood (2004) 104 (11): 5135.

https://doi.org/10.1182/blood.V104.11.5135.5135

Published: 2004

NARROW

Successful Peripheral Blood Stem Cell (PBSC) Mobilisation with G-CSF in Patients with Chronic Myeloid Leukaemia Achieving Complete Cytogenetic Remission with Imatinib.

Imatinib Achieves High Rates of Complete Citogenetic Remission (CCR) in CML Patients Relapsed after Autografting anf IFN-α Therapy.

Reduced Intensity Conditioning Regimen for Allografting Following Cytoreductive Autografting in Metastatic Breast Cancer.

Reduced Intensity Conditioning Regimen for Allografting Following Autografting Is Feasible and Has a Strong Anti Multiple Myeloma Activity.

Long-Term Follow-Up of CML Patients Treated with Autografting Followed by IFN-A and Imatinib for Relapsed Patients.

Reduced Intensity Conditioning Regimen for Allografting Following Cytoreductive Autografting in Relapsed/Resistant Hodgkin’s Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Successful Peripheral Blood Stem Cell (PBSC) Mobilisation with G-CSF in Patients with Chronic Myeloid Leukaemia Achieving Complete Cytogenetic Remission with Imatinib.

Imatinib Achieves High Rates of Complete Citogenetic Remission (CCR) in CML Patients Relapsed after Autografting anf IFN-α Therapy.

Reduced Intensity Conditioning Regimen for Allografting Following Cytoreductive Autografting in Metastatic Breast Cancer.

Reduced Intensity Conditioning Regimen for Allografting Following Autografting Is Feasible and Has a Strong Anti Multiple Myeloma Activity.

Long-Term Follow-Up of CML Patients Treated with Autografting Followed by IFN-A and Imatinib for Relapsed Patients.

Reduced Intensity Conditioning Regimen for Allografting Following Cytoreductive Autografting in Relapsed/Resistant Hodgkin’s Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only